New Retina Radio:

GA Options in Clinical Therapy

GAOption-Logo

12.12.24

GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?

What are the benefits and limitations to FDA-approved therapies for geographic atrophy? John Kitchens, MD, is joined by Saradha Chexal, MD, and Geeta Lalwani, MD, as they explore which patients are best suited for treatment, how best to succinctly set expectations for outcomes, and whether patients on GA therapy may also be well-suited AREDS vitamins.

Other Podcast Episodes

10.02.25

Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

12.12.24

GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?

John Kitchens, MD; Saradha Chexal, MD; and Geeta Lalwani, MD

10.28.24

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

John Kitchens, MD, Miguel Busquets, MD, and Esther Kim, MD

05.10.24

GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD

05.10.24

GA Options in Clinical Therapy, Part 2: Real-World Cases in GA

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD